Aflatoxins are potent carcinogens and pose significant risks to food safety and public health worldwide. Aflatoxins include Aflatoxin B1 (AFB1), Aflatoxin B2 (AFB2), Aflatoxin G1 (AFG1), Aflatoxin G2 (AFG2), and Aflatoxin M1 (AFM1). AFB1 is particularly notorious for its carcinogenicity, classified as a Group 1 human carcinogen by the International Agency for Research on Cancer (IARC). Chronic exposure to aflatoxins through contaminated food and feed can lead to liver cancer, immunosuppression, growth impairment, and other systemic health issues. Efforts to mitigate aflatoxin contamination have traditionally relied on chemical treatments, physical separation methods, and biological degradation. However, these approaches often pose challenges related to safety, efficacy, and impact on food quality. Recently, cold plasma treatment has emerged as a promising alternative. Cold plasma generates reactive oxygen species, which effectively degrade aflatoxins on food surfaces without compromising nutritional integrity or safety. This review consolidates current research and advancements in aflatoxin detoxification, highlighting the potential of cold plasma technology to revolutionize food safety practices. By exploring the mechanisms of aflatoxin toxicity, evaluating existing detoxification methods, and discussing the principles and applications of cold plasma treatment., Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. The publishing fee is covered under the Open access agreement between Springer Nature and Crue & CSIC. GY was supported by AYUDAS JUAN DE LA CIERVA-INCORPORACIÓN (IJC2020-044166-I)., Peer reviewed

The escalating threat of antimicrobial resistance calls for novel therapeutic agents. This study employed a ligand-based design approach to develop three series of N-arylpyrrole derivatives (Va–e, VIa–e, and VIIa–e), refined through molecular modeling. Synthesized compounds were evaluated against ESKAPE pathogens, MRSA, and Mycobacterium phlei. Series Va–e showed the most promise, with compounds Vb, Vc, and Ve outperforming levofloxacin against MRSA (MIC = 4 μg/mL vs. 8 μg/mL). Vc also exhibited activity against E. coli, K. pneumoniae, and A. baumannii, and showed significant inhibition against M. phlei (MIC = 8 μg/mL). Compounds were evaluated for antibiofilm and antivirulence properties, targeting resistance mechanisms linked to infection persistence and dissemination. Most exhibited broad-spectrum biofilm inhibition and antivirulence activity. Cytotoxicity studies revealed selectivity for bacterial cells. ADMET studies supported drug-like properties. Docking studies suggested UPPP inhibition as the potential mechanism. SAR analysis was conducted to support future optimizations., GY was supported by AYUDAS JUAN DE LA CIERVA-INCORPORACIÓN (IJC2020-044166-I). This work is also supported by the Ministerio deCiencia, Innovación y Universidades Spain., Peer reviewed

Polysaccharides derived from Pleurotus eryngii possess various bioactive properties, including antioxidant, antidiabetic, anti-inflammatory, and immunomodulatory effects. In this study, polysaccharides were extracted from P. eryngii fruiting bodies and exposed to gamma irradiation at doses of 50 and 100 kGy, with a dose rate of 5 kGy/h. The surface morphology of the polysaccharide irradiated at 100 kGy exhibited numerous pores and a smaller flake structure compared to those irradiated at 50 kGy and the non-irradiated sample. 1H and 13C NMR spectra of all samples indicated that both irradiated and non-irradiated polysaccharides exhibited α- and β-configurations, with signals corresponding to C1–C5 clearly observed. HPLC analysis of the polysaccharides revealed that glucose (75.23%), galactose (4.96%), glucuronic acid (1.38%), ribose (0.94%), rhamnose (2.35%), and mannose (3.87%) are the main components. All polysaccharides demonstrated antioxidant activity, which increased with concentration. Both non-irradiated and irradiated polysaccharides exhibited antidiabetic effects, significantly reducing blood glucose levels, and restoring insulin level with superiority of irradiated polysaccharides. Additionally, they significantly elevated body weight, slightly reduced MDA levels, and markedly enhanced catalase activity in treated rats compared to diabetic controls. The antidiabetic effects of the polysaccharides were further confirmed by histopathological examination of the pancreas and liver sections from polysaccharide-treated diabetic rats. This suggests that irradiation, by reducing the molecular weight of polysaccharides, enhances their bioavailability and efficacy in modulating glucose metabolism., The publishing fee is covered under the CRUE-CSIC open access (OA) agreement with Springer. GY was supported by AYUDAS JUAN DE LA CIERVA-INCORPORACIÓN (IJC2020-044166-I)., Peer reviewed